Tumor mutational burden and immune signatures interplay in renal cell carcinoma
Author(s) -
Evgeny Yakirevich,
Nimesh R. Patel
Publication year - 2020
Publication title -
annals of translational medicine
Language(s) - English
Resource type - Journals
eISSN - 2305-5847
pISSN - 2305-5839
DOI - 10.21037/atm.2020.02.81
Subject(s) - renal cell carcinoma , immune system , cancer research , carcinoma , biology , medicine , computational biology , oncology , immunology , genetics
Department of Pathology, Rhode Island Hospital and Alpert Medical School at Brown University, Providence, RI, USA Correspondence to: Evgeny Yakirevich, MD, DSc. Department of Pathology, Rhode Island Hospital, 593 Eddy Street, APC12, Providence, RI 02903, USA. Email: eyakirevich@lifespan.org. Provenance: This is an invited article commissioned by the Editorial Office, Annals of Translational Medicine. Comment on: Zhang C, Li Z, Qi F, et al. Exploration of the relationships between tumor mutation burden with immune infiltrates in clear cell renal cell carcinoma. Ann Transl Med 2019;7:648.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom